GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » China Isotope & Radiation Corp (HKSE:01763) » Definitions » Total Assets

China Isotope & Radiation (HKSE:01763) Total Assets : HK$14,429 Mil (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is China Isotope & Radiation Total Assets?

China Isotope & Radiation's Total Assets for the quarter that ended in Dec. 2023 was HK$14,429 Mil.

Warning Sign:

If a company builds assets at 17% a year, faster than its revenue growth rate of 12.8% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, China Isotope & Radiation's average Total Assets Growth Rate was 14.10% per year. During the past 3 years, the average Total Assets Growth Rate was 12.70% per year. During the past 5 years, the average Total Assets Growth Rate was 17.00% per year.

During the past 9 years, China Isotope & Radiation's highest 3-Year average Total Assets Growth Rate was 32.90%. The lowest was 12.70%. And the median was 23.30%.

Total Assets is connected with ROA %. China Isotope & Radiation's annualized ROA % for the quarter that ended in Dec. 2023 was 3.91%. Total Assets is also linked to Revenue through Asset Turnover. China Isotope & Radiation's Asset Turnover for the quarter that ended in Dec. 2023 was 0.31.


China Isotope & Radiation Total Assets Historical Data

The historical data trend for China Isotope & Radiation's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Isotope & Radiation Total Assets Chart

China Isotope & Radiation Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial Premium Member Only 9,840.47 10,888.55 12,901.84 13,165.76 14,428.81

China Isotope & Radiation Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12,901.84 12,751.19 13,165.76 12,903.13 14,428.81

China Isotope & Radiation Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

China Isotope & Radiation's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=7808.846+6619.968
=14,429

China Isotope & Radiation's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (Q: Dec. 2023 )+Total Liabilities (Q: Dec. 2023 )
=7808.846+6619.968
=14,429

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China Isotope & Radiation  (HKSE:01763) Total Assets Explanation

Total Assets is connected with ROA %.

China Isotope & Radiation's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %=Net Income (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=533.918/( (12903.126+14428.814)/ 2 )
=533.918/13665.97
=3.91 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

China Isotope & Radiation's Asset Turnover for the quarter that ended in Dec. 2023 is

Asset Turnover
=Revenue (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=4259.619/( (12903.126+14428.814)/ 2 )
=4259.619/13665.97
=0.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

China Isotope & Radiation Total Assets Related Terms

Thank you for viewing the detailed overview of China Isotope & Radiation's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


China Isotope & Radiation (HKSE:01763) Business Description

Traded in Other Exchanges
N/A
Address
No. 66 Changwa Middle Street, Haidian District, Beijing, CHN, 100089
China Isotope & Radiation Corp is a Chinese company. It has five operating segments: Pharmaceuticals; Radioactive source products; Irradiation; Radiation therapy equipment and related services and Other businesses. Its Pharmaceutical segment is the key revenue driver, which manufactures and sells imaging diagnostic and therapeutic radiopharmaceuticals imaging, UBT diagnostic kits, and test analyzers, and other products. Its radioactive source products segment involves the sale of medical and industrial radioactive source products and technical services. The Group's operations are carried out and majority of the Group's customers are located in the PRC.

China Isotope & Radiation (HKSE:01763) Headlines

No Headlines